Logo


Press Releases

WorldCare Clinical Publishes Research Manuscript Demonstrating How a Central Image Review Can Reduce Overall Clinical Trial Costs
November 12, 2013 - read more
WorldCare Clinical Collaborates with Leading Researcher to Publish an Endpoint Assessment Committee Review Article
October 29, 2013 - read more
ProScan Imaging Group Acquires 100 Percent Ownership of WorldCare Clinical LLC
October 15, 2013 - read more
WorldCare Clinical Appoints Melissa Gebhardt to Lead Business Development and Marketing Strategy
October 09, 2013 - read more
WorldCare Clinical Introduces New Service for Oncology Imaging Studies Involving Immune-Related Response Criteria (irRC)
August 08, 2013 - read more
More 'Press Releases'...

Industry News

The Cancer Immunotherapy Market Will Increase to Nearly $9 Billion Across the World's Major Pharmaceutical Markets in 2022
June 30, 2014 - read more - source
Companies Chasing Gold Nugget of Immuno-Oncology Like Never Before
June 26, 2014 - read more - source
Virus that helped eradicate smallpox takes on cancer in startup's dual-mechanism immunotherapy
May 30, 2014 - read more - source
Immune Therapy’s Cancer Promise Creates Research Rush
May 29, 2014 - read more - source
AstraZeneca, Bristol-Myers add immuno-oncology collaborations for pipeline stars
May 14, 2014 - read more - source
More 'Industry News'...

In The News

Outsourcing-Pharma.com – WorldCare Clinical has launched a blinded independent safety and efficacy review service to speed FDA approval of clinical trial data.
October 02, 2012 - source
TODAY ON PHARMALIVE.COM – WorldCare Clinical Unveils New Services for Trials with Subjective Endpoints
June 01, 2012 - source
Contract Pharma - WorldCare Clinical Names Kenneth O’Brien Executive Director of Quality & Regulatory Affairs.
April 18, 2012 - source
PharmaVoice - What's New
April 01, 2012 - source
PharmaVoice - Imaging in Clinical Trials – Removing Bias and Increasing Precision and Accuracy.
April 01, 2012 - source
More 'In The News'...